Publication | Closed Access

Haploidentical HCT using an αβ T-cell-depleted graft with targeted αβ+ cells by add-back after a reduced intensity preparative regimen containing low-dose TBI

Low-dose TbiCell TherapyTransplantationImmunologyHematologyGraft SurvivalTargeted αβ+ CellsCell TransplantationHaploidentical HctBlood TransplantationMedicineRadiation OncologyGraft RejectionHealth Sciences